Antibody targeting of E3 ubiquitin ligases for receptor degradation
Hadir Marei(University of Manchester), Felipe de Sousa e Melo(Gene Therapy Laboratory), Meena Choi(Translational Genomics Research Institute), Frédéric J. de Sauvage(Gene Therapy Laboratory), Kristel M. Dorighi, Yee-Seir Kee, Elaine Mai(Snap (United States)), Laëtitia Comps‐Agrar(Gene Therapy Laboratory), Chris Cox, Hongkang Xi, Nicholas J. Agard(University of California, San Francisco), Jieyan He, Noelyn M. Kljavin, Andrew G. Mancini(Molecular Oncology (United States)), Melanie Heinlein(Molecular Oncology (United States)), Pamela Zhang, Tao Sun(Stanford University), Isabelle Lehoux, Seth F. Harris, Brian Biehs(Molecular Oncology (United States)), Dhara N. Amin, Pankaj Dwivedi(University of Cincinnati), Dhaya Seshasayee(Biogen (United States)), Yvonne T. Kschonsak, Wen‐Ting K. Tsai, Eric Janezic(University of Washington), Sai C. Penikalapati, Matthew Grimmer(Sequenom (United States)), David Kan, Pablo Sáenz-López, Ingrid Kim, Chunling Wang(Huizhou University), Jia Wu, Chen Gu(Shinshu University), Karen Ruiz, Alexander Doan(Stanford University), Jing Li(Donghua University), Thao Nguyen(Molecular Oncology (United States))
Cited by 254
Related Papers
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
|Cancer Cell|2014|1.1k
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
|Nature Biotechnology|2012|997
Recurrent R-spondin fusions in colon cancer
|Nature|2012|973
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells
|Nature Immunology|2006|825
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795